Log in to save to my catalogue

Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with hi...

Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with hi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04352855v1

Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study

About this item

Full title

Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study

Publisher

Springer Nature

Journal title

BMC primary care, 2023-11, Vol.23 (1)

Language

English

Formats

Publication information

Publisher

Springer Nature

More information

Scope and Contents

Contents

ABSTRACTIntroductionApproximately 130 000 infants acquire HIV annually despite global maternal antiretroviral therapy scale-up. We evaluated the potential clinical impact and cost-effectiveness of offering long-acting, anti-HIV broadly neutralizing antibody (bNAb) prophylaxis to infants in three distinct settings.MethodsWe simulated infants in Côte...

Alternative Titles

Full title

Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis in settings with high HIV burdens: a simulation modeling study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_hal_primary_oai_HAL_hal_04352855v1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_hal_04352855v1

Other Identifiers

ISSN

2731-4553

E-ISSN

2731-4553

DOI

10.1101/2023.11.06.23298184

How to access this item